Papers
2
Total Citations
9
H-Index
2
About
Dongbing Zhao is a leading surgical oncologist whose research focuses on improving outcomes for patients with hepatopancreatobiliary malignancies, particularly ampullary carcinoma and bile duct injuries. His major contributions include the development of novel prognostic scoring systems, such as the preoperative total bilirubin-albumin ratio combined with the fibrinogen-albumin ratio, which offers a more accurate risk stratification for ampullary adenocarcinoma patients. He has also pioneered the concept of “textbook outcomes” for ampullary carcinoma patients undergoing pancreaticoduodenectomy, providing a composite benchmark for surgical quality and patient recovery. His work on postcholecystectomy bile duct injury (BDI) has shed light on the persistent burden of this devastating iatrogenic complication, emphasizing the need for improved prevention and management strategies. With his most-cited paper accumulating 6 citations and his innovative prognostic models gaining traction, Zhao’s research is shaping how surgeons evaluate and treat complex biliary and pancreatic conditions. His achievements highlight a commitment to translating clinical data into actionable tools that enhance surgical decision-making and patient survival.
Research Focus
Key Achievements
Top Papers
- 1
- 2